68 completed, 14 unknown, 12 terminated, 2 withdrawn. 97 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 97 | Completed 68, Unknown 14, Terminated 12, Withdrawn 2, Recruiting 1 |
Follow Sitagliptin: new trials by email Literature Review of Sitagliptin trials Research Report on Sitagliptin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes. Metformin, Dulaglutide, Semaglutide 1.0 mg - Diabetes Mellitus Type 2 | Phase 4 | Completed | Fundación para la Investigación del Hospital Clínico de Valencia | 92 | 2025-05-26 | 2026-09-04 |
| Efficacy and Safety of Canagliflozin in the Treatment of Type 2 Diabetes With Mild Cognitive Impairment Canagliflozin group, Sitagliptin, Acarbose - Type 2 Diabetes Mellitus, Cognitive Impairment | Phase 4 | Recruiting | Fudan University | 60 | 2024-08-19 | 2026-07-17 |
| Anti-Diabetic Medications to Fight PD and LBD Sitagliptin, Dapagliflozin, Placebo - Lewy Body Dementia, Parkinson Disease | Phase 4 | Completed | Mayo Clinic | 18 | 2024-05-07 | 2026-01-28 |
| Sitagliptin in Combination With Beidougen Capsule for Type 2 Diabetes Sitagliptin, Sitagliptin combined with Beidougen capsule - Type 2 Diabetes | Phase 4 | Unknown | Beijing Chao Yang Hospital | 20 | 2022-12-01 | 2023-01-03 |
| The Effect of Glimepiride Compared With Sitagliptin as an add-on Therapy to Metformin in Severe Insulin Deficiency Diabetes Glimepiride, Sitagliptin - Diabetes Mellitus, Type 2, Severe Insulin Deficient Diabetes | Phase 4 | Unknown | Peking University People's Hospital | 192 | 2022-01-01 | 2022-05-23 |
| Efficacy of Metformin Versus Sitagliptin on Benign Thyroid Nodules in Type 2 Diabetes METFORMIN, Sitagliptin - Diabetes Mellitus, Type 2, Thyroid Nodule (Benign) | Phase 4 | Unknown | Centre Hospitalier Universitaire de la Guadeloupe | 90 | 2021-01-01 | 2020-09-11 |
| Approaches To Therapy Escalation In T2D DPP-4 inhibitor, SGLT2 inhibitor, SGLT2 inhibitor and DPP-4 inhibitor - Type2 Diabetes | Phase 4 | Withdrawn | LMC Diabetes & Endocrinology Ltd. | 2019-05-01 | 2019-09-27 | |
| Effect of Neprilysin on Glucagon-Like Peptide-1 in Patients With Type 2 Diabetes Entresto, Sitagliptin, Valsartan - Type2 Diabetes | Phase 4 | Completed | University of Copenhagen | 12 | 2019-01-25 | 2021-05-05 |
| Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1 Valsartan, LCZ696, Bradykinin - Hypertension | Phase 4 | Terminated | Vanderbilt University Medical Center | 4 | 2018-11-15 | 2025-08-03 |
| Effects of a Dipeptidyl Peptidase-4 Inhibitor Sitagliptininsulin on the Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes Sitagliptin, Acarbose - Atherosclerosis Type 2 Diabetes Mellitus Dipeptidyl Peptidase-4 Inhibitor GLP-1 | Phase 4 | Unknown | Chinese PLA General Hospital | 300 | 2018-10-01 | 2018-07-27 |
| Empagliflozin Versus Sitagliptin Therapy for Improvement of Myocardial Perfusion Reserve in Diabetic Patients With Coronary Artery Disease Empagliflozin, Sitagliptin - Diabetes Mellitus, Coronary Disease | Phase 4 | Completed | CHEOL WHAN LEE, M.D., Ph.D | 100 | 2017-08-07 | 2019-08-07 |
| Cardiovascular Effects of GLP-1 Receptor Activation Liraglutide, Sitagliptin, hypocaloric diet - Obesity, PreDiabetes | Phase 4 | Completed | Vanderbilt University Medical Center | 329 | 2017-05-01 | 2022-10-18 |
| Mechanistic Evaluation of Glucose-lowering Strategies in Patients With Heart Failure Saxagliptin, Sitagliptin, Placebo to match saxagliptin - Type 2 Diabetes Mellitus, Heart Failure | Phase 4 | Completed | AstraZeneca | 348 | 2017-01-10 | 2021-11-08 |
| Treatment of Diabetes in Patients With Systolic Heart Failure Canagliflozin, Sitagliptin - Heart Failure, Systolic, Diabetes Mellitus, Type 2 | Phase 4 | Completed | Virginia Commonwealth University | 36 | 2016-10-01 | 2019-10-29 |
| Sitagliptin Improved Beta Cell Function and Prevented a Conversion Rate to Impaired Glucose Tolerance and Type 2 Diabetes in Metformin Intolerant Obese Women With Polycystic Ovary Syndrome Sitagliptin, Lifestyle intervention - PCOS | Phase 4 | Completed | University Medical Centre Ljubljana | 30 | 2016-08-01 | 2017-04-20 |
| The Effect of DPP4 Inhibitor on Vasclular Healing Sitagliptin, Non DPP-4 Inhibitor - Acute Coronary Syndrome, Diabetes Mellitus, Type 2 | Phase 4 | Unknown | Chung-Ang University | 66 | 2016-06-01 | 2016-06-16 |
| Sitagliptin in Non-Diabetic Patients Undergoing General Surgery Sitagliptin, Placebo, Supplemental insulin (insulin lispro) - Hyperglycemia | Phase 4 | Completed | Emory University | 80 | 2016-06-01 | 2018-06-27 |
| SNP Study of DPP-4 and GLP-1R in Chinese People (Including Diabetes Patients) Sitagliptin - Diabetes Mellitus | Phase 4 | Completed | Sichuan Provincial People's Hospital | 119 | 2016-04-21 | 2020-07-30 |
| Drug Transporter Interaction Study PHENTRA_2015_KPUK pitavastatin, Metformin, digoxin - Healthy | Phase 4 | Completed | University of Cologne | 24 | 2016-04-01 | 2019-09-10 |
| The Effect of Dipeptidyl Peptidase 4 Inhibition on Growth Hormone Secretion in Women With Polycystic Ovarian Syndrome Sitagliptin, Placebo - Polycystic Ovary Syndrome | Phase 4 | Completed | Vanderbilt University | 23 | 2016-02-01 | 2020-05-08 |
Showing 20 of 97. Sign in to see all of them.
Diabetes Mellitus, Type 2 (63) · Diabetes Mellitus (27) · Hyperglycemia (7) · Diabetes Mellitus, Type 1 (5) · Insulin Resistance (5) · Glucose Intolerance (3) · Atherosclerosis (2) · Coronary Disease (2) · Hypertension (2) · Hypoglycemia (2) · Obesity (2) · Acromegaly (1) · Acute Coronary Syndrome (1) · Angina, Unstable (1) · Cognitive Dysfunction (1)
Emory University (5) · Vanderbilt University (4) · AstraZeneca (3) · Lund University (3) · Merck Sharp & Dohme LLC (3) · Novartis Pharmaceuticals (3) · Novo Nordisk A/S (3) · Sanofi (3) · Mayo Clinic (2) · Seoul National University Bundang Hospital (2) · Shanghai Jiao Tong University School of Medicine (2) · The Catholic University of Korea (2) · University of Colorado, Denver (2) · University of Missouri-Columbia (2) · Vanderbilt University Medical Center (2)
United States (38) · China (10) · South Korea (10) · Germany (8) · India (6) · Japan (5) · Brazil (4) · Spain (4) · Sweden (4) · United Kingdom (4) · Denmark (3) · Netherlands (3) · Thailand (3) · Turkey (Türkiye) (3) · Austria (2)
Guillermo Umpierrez, MD (4) · Guang Ning, MD. PHD (2) · Adrian Vella, M.D. (1) · Amy Warriner, MD (1) · Angelo Avogaro, MD PhD (1) · Anton Cheng, MBBS (1) · Antonio Abbate, MD, PhD (1) · Antonio Ceriello, MD (1) · Asger Lund, MD (1)
PMID 11495032, PMID 16400329, PMID 17622601, PMID 18786299, PMID 19723493, PMID 19880582, PMID 20039889, PMID 20357375, PMID 20679179, PMID 21550951, PMID 21923696, PMID 22443183, PMID 22456695, PMID 22683131, PMID 22775317, PMID 22809630, PMID 23186950, PMID 23331498, PMID 23490599, PMID 23579178, PMID 23877988, PMID 25283485, PMID 25457473, PMID 25488587, PMID 26586327, PMID 27038451, PMID 27060930, PMID 27381275, PMID 27405306, PMID 27451030, PMID 27573938, PMID 27585605, PMID 27627981, PMID 27964837, PMID 28145158, PMID 28271251, PMID 28345162, PMID 28671753, PMID 29435776, PMID 29478970, PMID 29607050, PMID 29770541, PMID 30145664, PMID 31189978, PMID 31247117, PMID 31529097, PMID 31733647, PMID 32475838, PMID 32539832, PMID 32719417
K23HL119602 (2), 2008 (1), 2019 (1), 2025 (1), R03DK084089 (1), U54RR014616 (1)